bioRxivBiochemistry
Type III CRISPR-Cas systems generate cyclic oligoadenylate second messengers to activate Csm6 RNases
O. Niewoehner, C. Garcia-Doval, J. T. Rostol, C. Berk, F. Schwede, L. Bigler, J. Hall, L. Marraffini, M. Jinek
Abstract
In many prokaryotes, type III CRISPR-Cas systems detect and degrade invasive genetic elements by an RNA-guided, RNA-targeting multisubunit interference complex that possesses dual RNase and DNase activities. The CRISPR-associated protein Csm6 additionally contributes to interference by functioning as a standalone ribonuclease that degrades invader RNA transcripts, but the mechanism linking invader sensing to Csm6 activity is not understood. Here we show that Csm6 proteins are activated through a second messenger generated by the type III interference complex. Upon target RNA binding by the type III interference complex, the Cas10 subunit converts ATP into a cyclic oligoadenylate product, which allosterically activates Csm6 by binding to its CARF domain. CARF domain mutations that abolish allosteric activation inhibit Csm6 activity in vivo, and mutations in the Cas10 Palm domain phenocopy loss of Csm6. Together, these results point to a hitherto unprecedented mechanism for regulation of CRISPR interference that bears striking conceptual similarity to oligoadenylate signalling in mammalian innate immunity.
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: protein folding & dynamics
- approach: experimental assay
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6
C. Garcia-Doval, F. Schwede, … M. Jinek·bioRxiv·Feb 19, 2020
- Mechanistic Insights into Cyclic Penta-Adenylate-Mediated Activation of Type III CRISPR Ribonuclease Csm6
Ruyi Shi, Mengquan Yang, … Zhonghui Lin·bioRxiv·Oct 25, 2025
- Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
J. S. Athukoralage, C. Rouillon, … M. F. White·bioRxiv·Jul 30, 2018
- Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase
Jinzhong Lin, Mingxia Feng, … Qunxin She·Cell DiscoveryPeer-reviewed·May 11, 2020
- Structure and Function of an in vivo Assembled Type III-A CRISPR-Cas Complex Reveal Critical Roles of Dynamics in Activity Control
S. Sridhara, J. Rai, … H. Li·bioRxiv·Jan 27, 2021
- Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate
S. A. McMahon, W. Zhu, … T. M. Gloster·bioRxiv·Sep 26, 2019